Associate Professor
University of Pennsylvania
Philadelphia, PA, United States
Rahul Kohli obtained his MD and PhD from the Harvard, where he completed his PhD studies in Biochemistry with Dr. Christopher T. Walsh. He carried out his clinical infectious diseases training at Johns Hopkins University where he also completed post-doctoral studies under Dr. James Stivers. In 2010, Dr. Kohli joined the faculty at Penn in a role bridging the Department of Medicine and the Department of Biochemistry and Biophysics. The chief objective of his research group has been to probe DNA modifying enzymes and pathways, using approaches rooted in enzymology and chemical biology. The enzymes targeted by his group’s studies catalyze the purposeful introduction of mutations, and the processes of interest are central to host-pathogen interactions or to epigenetics. Dr. Kohli’s work has been recognized through support from the Burroughs Wellcome Foundation, Doris Duke Foundation, Rita Allen Foundation and an NIH Director's New Innovator Award, among others. He has been elected to the American Society for Clinical Investigators and was the 2020 recipient of the American Chemical Society Pfizer Award in Enzyme Chemistry.
Cambridge Epigenetix (Individual(s) Involved: Self): Board Member; LifeEdit Inc. (Individual(s) Involved: Self): Board Member
37 - Eat the Apple: Genesis of Antimicrobial Resistance
Thursday, September 30, 2021
3:45 PM - 5:00 PM EDT
Disarming the Bacterial DNA Damage Response to Combat Antibiotic Resistance
Thursday, September 30, 2021
3:45 PM - 5:00 PM EDT